Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept

Figure 1

Representative case with RPE loss of a patient receiving intravitreal ranibizumab.